Parallax Volatility Advisers, L.P. Paratek Pharmaceuticals, Inc. Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $35,419 - $85,596	-7,379 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$9.05 - $10.95 $16,661 - $20,158	-1,841 Reduced 19.97%	7,379 $72,000
Q2 2018 Aug 14, 2018	SELL	$10.2 - $13.9 $33,445 - $45,578	-3,279 Reduced 26.23%	9,220 $94,000
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $2,112 - $3,147	167 Added 1.35%	12,499 $162,000
Q4 2017 Feb 14, 2018	SELL	$17.45 - $25.6 $187,255 - $274,713	-10,731 Reduced 46.53%	12,332 $221,000
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $435,890 - $650,376	23,063	23,063 $579,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.